MD SB312 | 2019 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 7-0)
Status: Introduced on January 30 2019 - 25% progression, died in committee
Action: 2019-02-11 - Hearing 3/06 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 30 2019 - 25% progression, died in committee
Action: 2019-02-11 - Hearing 3/06 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Prohibiting an insurer, based solely on information about the purchase or possession of an opioid overdose reversal drug by an applicant or insured or a prescription for an opioid overdose reversal drug prescribed to an applicant or insured, from taking certain actions relating to a policy of life insurance; and applying the Act to life insurance policies issued, delivered, or renewed in the State on or after January 1, 2020.
Title
Life Insurance - Prohibition on Discrimination - Opioid Overdose Reversal Drug
Sponsors
| Sen. Clarence Lam [D] | Sen. William Ferguson [D] | Sen. Katherine Klausmeier [D] | Sen. Obie Patterson [D] |
| Sen. Paul Pinsky [D] | Sen. Jim Rosapepe [D] | Sen. Ronald Young [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-02-11 | Senate | Hearing 3/06 at 1:00 p.m. |
| 2019-01-30 | Senate | First Reading Finance |
